Avacta Group PLC JV AffyXell agrees drug development collaboration

The deal should enhance the translation of AffyXell’s programmes into human trials and accelerate drug development Avacta Group PLC (AIM:AVCT) said AffyXell Therapeutics, its joint venture with Daewoong Pharmaceutical, has entered into a collaboration with Chinese biological drugs developer Biocytogen and the Korea Non-Clinical Technology Solution Centre (KNTSC). The collaboration is …

Read More »